Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KCPS superintendent to city struggling with violence: When do we all come together?
It’s inexcusable for Kansas City to simply accept 130 murders before it’s even December, Mark Bedell said. “Who do you think are committing these crimes?” Bedell, superintendent of Kansas City Public Schools, asked a crowd gathered Thursday for the Lean Lab’s Launch[ED) Day. “Probably people who have been victims of schools that have failed them…
Kauffman Foundation rolls out $1.2M microlending program to help underserved entrepreneurs
Amid a swarm of 160 events as part of Global Entrepreneurship Week, the Ewing Marion Kauffman Foundation announced a new microlending program to spur investment in underserved entrepreneurs. In partnership with four microfinance lenders, the foundation issued a series of grants totaling $1.2 million that a will change the way the nonprofit microlenders capitalize their…
Scared away from networking events? Anti-social introverts can turn to tech
Networking strength comes in numbers — even for anti-social introverts, Jeremy A. Smith told a crowd Tuesday at Global Entrepreneurship Week. “Anti-social people, myself included, hate events,” he said. But like all other entrepreneurs, such introverts still must build and maintain actionable professional networks from which they can request and receive value, Smith said. In-person networking…
Longfellow Farm coworking the soil amid KC’s urban food desert
In a city ripe with coworking office spaces, there’s a hunger for similar environments outdoors, Ami Freeberg said. As with maintaining individual workplaces, traditional urban farming also can be isolating and expensive, the Longfellow Farm manager said. By working together, however, the collaborative process allows for shared resources, greater human expertise and, of course, more…